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Abstract: We report the discovery and functional characterization of αM-Conotoxin MIIIJ, a peptide
from the venom of the fish-hunting cone snail Conus magus. Injections of αM-MIIIJ induced
paralysis in goldfish (Carassius auratus) but not mice. Intracellular recording from skeletal muscles
of fish (C. auratus) and frog (Xenopus laevis) revealed that αM-MIIIJ inhibited postsynaptic nicotinic
acetylcholine receptors (nAChRs) with an IC50 of ~0.1 µM. With comparable potency, αM-MIIIJ
reversibly blocked ACh-gated currents (IACh) of voltage-clamped X. laevis oocytes exogenously
expressing nAChRs cloned from zebrafish (Danio rerio) muscle. αM-MIIIJ also protected against
slowly-reversible block of IACh by α-bungarotoxin (α-BgTX, a snake neurotoxin) and α-conotoxin EI
(α-EI, from Conus ermineus another fish hunter) that competitively block nAChRs at the ACh binding
site. Furthermore, assessment by fluorescence microscopy showed thatαM-MIIIJ inhibited the binding
of fluorescently-tagged α-BgTX at neuromuscular junctions of X. laevis, C. auratus, and D. rerio. (Note,
we observed thatαM-MIIIJ can block adult mouse and human muscle nAChRs exogenously expressed
in X. laevis oocytes, but with IC50s ~100-times higher than those of zebrafish nAChRs.) Taken together,
these results indicate that αM-MIIIJ inhibits muscle nAChRs and furthermore apparently does so
by interfering with the binding of ACh to its receptor. Comparative alignments with homologous
sequences identified in other fish hunters revealed that αM-MIIIJ defines a new class of muscle
nAChR inhibitors from cone snails.
Keywords: venom; conotoxin; nicotinic acetylcholine receptor; neuromuscular junction
Key Contribution: We report the discovery and neurophysiological characterization of the first
member of a class of muscle nAChR antagonists from venomous marine cone snails.
1. Introduction
Cone snail venoms have a profusion of peptides that target ion channels of the nervous system [1–3].
Owing to their diversity and target specificity, cone snail toxins (conotoxins) have become valuable
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tools for ion channel research and drug design [3–5]. Cone snails form a diverse genus of ~800 extant
species that have evolved diverse diets and predation strategies. Conus magus belongs to one of the
most studied clades of fish-hunting cone snails, the Pionoconus clade. Pionoconus cone snails use the
taser-and-tether hunting strategy that is characterized by rapid, irreversible paralysis following venom
injection [6]. This is achieved by the concerted action of toxins that target ion channels and receptors
of the peripheral nervous system, particularly those at the neuromuscular junction [7]. Many of the
paralytic components of Pionoconus venom have been characterized. For example, the venom of the
fish hunter Conus magus has three families of paralytic peptides, and a representative member of
each family is as follows: α-conotoxin MI, which blocks postsynaptic nicotinic acetylcholine receptors
(nAChRs) that are essential for excitatory postsynaptic potentials (EPSPs) in muscle fibers;ω-conotoxin
MVIIA, which blocks voltage-gated calcium channels (V-gated Ca channels) whose activity triggers
transmitter (acetylcholine, ACh) release from the presynaptic motor-nerve terminal; and µ-conotoxin
MIIIA, which blocks voltage-gated sodium channels (V-gated Na channels) responsible for action
potentials in muscle fibers (see Table 1 for peptide sequences and references). Here, we describe the
identification of αM-MIIIJ, the first member of a previously uncharacterized family of paralytic toxins
with functional but no structural similarity to α-conotoxin MI.
Table 1. Sequences and targets of paralytic conotoxins from C. magus.
Peptide Sequence 1 Ion-Channel Target Reference
α-MI GRCCHPACGKNYSC# muscle nAChR McIntosh 1982 [8]
α-MII 2 GCCSNPVCHLEHSNLC# neuronal nAChR Cartier 1996 [9]
ω-MVIIA CKGKGAKCSRLMYDCCTGSCRSGKC# presynaptic Ca channel Olivera 1987 [10]
µ-MIIIA ZGCCNVPNGCSGRWCRDHAQCC# muscle Na channel Wilson 2011 [11]Zhang 2006 [12]
αM-MIIIJ ZKCCSGGSCPLYFRDRLICPCC muscle nAChR Rybin 2020 [this report]
1 Cysteine residues are bolded to highlight them; # indicates C-terminal amidation; Z indicates pyroglutamate
residue. 2 α-MII is not paralytic but is shown here for comparison with α-MI.
αM-MIIIJ was originally identified by fractionation of C. magus venom and sequencing of some
of its major components during the purification and characterization of α-MI by McIntosh et al. in
1982 [8]. Because αM-MIIIJ did not elicit a visible phenotype upon intracranial injections into mice
and was inactive in blocking synaptic transmission at the neuromuscular junction of the grass frog,
Rana pipiens, the pharmacological characterization of this toxin was not further pursued, and the
discovery of this peptide not reported.
Here, using electrophysiological experiments, we demonstrate that αM-MIIIJ blocks the function
of nAChRs at the neuromuscular junctions (NMJs) of African clawed frog (Xenopus laevis) and goldfish
(Carassius auratus). We confirm that αM-MIIIJ does not block nAChRs at the NMJ of R. pipiens. We
also show that αM-MIIIJ reversibly blocks muscle nAChRs cloned from zebrafish (Danio rerio) and
exogenously expressed in X. laevis oocytes; moreover, αM-MIIIJ protects these receptors from block
by α-bungarotoxin (α-BgTX) and α-conotoxin EI (α-EI). We believe this is the first report where an
nAChR-targeting conotoxin from a fish hunter has been functionally tested on molecularly-defined
fish nAChRs. Finally, we show by fluorescence microscopy that αM-MIIIJ inhibits the binding of
fluorescently-labeled α-BgTX to nAChRs at NMJs of frog (X. laevis, but not R. pipiens) and both goldfish
and zebrafish. Mining of published transcriptome data of C. magus and related cone snail species
suggests that αM-MIIIJ is the first functionally characterized member of a large class of toxins expressed
in taser-and-tether cone snails.
2. Results
2.1. αM-MIIIJ Discovery
αM-MIIIJ was discovered, albeit not reported, during our initial purification of α-MI [8]. Upon
reversed-phase fractionation of crude venom from C. magus, αM-MIIIJ eluted considerably later
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than α-MI (Figure S1). Further purification and sequencing of the reversed-phase fraction led to
the structural characterization of αM-MIIIJ. αM-MIIIJ has 22 amino acids including an N-terminal
pyro-glutamate (Figure 1A), and a molecular mass of 2429 Da (see below). Furthermore, αM-MIIIJ
has six cysteines connected by three disulfide bonds and exhibits a type III cysteine framework
(CC-C-C-CC) [13]. Mining of the venom gland transcriptome of C. magus and two other species from
the Pionoconus clade, Conus consors and Conus striatus, identified several toxins with high sequence
similarity to αM-MIIIJ (Figure 1A). Of these, the C. consors peptides (CnIIIE, CnIIIF, CnIIIG) were
previously shown to be part of the injected venom cocktail of this species, but their activity was not
explored [14].
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αM-MI J it ces of unknown activity identified in C. magus, C. c nsors, and C. striatus
(top) and -s l notoxins (bottom) that block V-gated Na channels (µ-prefix) or nAChRs
(ψ-prefix for i i co petitive site). Cysteines are in bold. Identical amino acids are shown
with ar owhead o - IJ sequence. Z: pyroglutamic acid, O: hydroxyproline, #: C-terminal
amidation. References [12,14–20]. B. Precursor sequ nce alignme t of M-superfamily toxins highlights
a conserved signal sequence used for toxin gene classification. The precursor sequence of αM-MIIIJ
could not be retrieved, but high sequence similarities with αM-MIIIJ-like sequences, including MIIIK
(91%), strongly suggest that αM-MIIIJ also belongs to the M-superfamily. Amino acid conservations
are denoted by an asterisk (*). Full stops (.) and colons (:) represent a low and high degree of
similarity, respectively.
Ac ordi t t i r ed -terminal signal sequence, c notoxins can be grouped into
genetically relate t xi s erfa ilies [3]. While we were not able to retrieve the precursor sequence
of αM-MIIIJ, the full-length precursors of highly similar sequences could be unambiguously assigned
to the M-superfamily (Figure 1B) [21] strongly suggesting that αM-MIIIJ is also a member of the
M-superfamily. For example, αM-MIIIJ and MIIIK share 74% sequence identity and 91% sequence
similarity. The absence of an identical sequence to αM-MIIIJ in the published transcriptome data of
C. magus can be attributed to the high intraspecies sequence variation of cone snail toxins. The venom
used in our study was not extracted from the same specimen as that used for transcriptome sequencing.
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Thus, we did not necessarily anticipate finding an exact sequence match but believe that the difference
in amino acid sequence is due to intraspecies variation. αM-MIIIJ was named according to the
conventional conotoxin nomenclature, where the Greek letter represents the pharmacological class
(“α” for inhibitors of nAChRs), followed by a single letter for the gene family (“M” for M-superfamily),
one or two letters representing the species name (“M” for magus), a Roman numeral for the cysteine
framework (“III”) and a letter or number given to identify different toxins belonging to the same
class (“J”).
2.2. αM-MIIIJ Synthesis
Solid-phase synthesis was carried out as described in Methods. The final product showed 98%
purity by analytical HPLC. The observed monoisotopic (M + H)+ value of the synthetic peptide was
2428.6, which corresponded with the calculated (M+H)+ value of 2429.0. The peptide was co-injected
with the venom-purified peptide and analyzed by capillary zone electrophoresis (CZE); there was no
difference in the migration between the native and the synthetic peptide.
2.3. Paralytic Effects of αM-MIIIJ
In-vivo assays revealed that αM-MIIIJ paralyzed goldfish (Table S1) but not mice. Three Swiss
Webster mice (22.34, 8.65, 8.52 g) were injected intraperitoneally (i.p.) with αM-MIIIJ (~2.3 nmol/g
mouse) and observed without any reduced motor function or paralysis for >1.5 h. For comparison, a
mouse (8.28 g) was injected i.p. with α-conotoxin EI (α-EI, 0.24 nmol/g mouse), an antagonist of muscle
nAChRs [22], that caused paralysis and then death in <10 min. This initial observation suggested
muscle nAChR may not be the molecular target of αM-MIIIJ, at least not in mice. To identify its
molecular target, we examined the effect of αM-MIIIJ on isolated muscle preparations from lower
vertebrates, namely two species each of frog and fish as well as on cloned muscle nAChRs of zebrafish
exogenously expressed in X. laevis oocytes.
2.4. Extracellular Electrophysiology of Frog Muscle Preparations
αM-MIIIJ readily blocked extracellularly-recorded action potentials in X. laevis longitudinal
pectoralis (LP) muscle evoked by motor-nerve stimulation (Figure 2A) but not those evoked by direct
muscle stimulation (Figure 2B). The resistance of directly-evoked action potentials toαM-MIIIJ indicates
that V-gated Na channels in the muscle were not blocked by the peptide. To examine the susceptibility of
synaptic potentials to the peptide, preparations were treated with µ-PIIIA, a conotoxin that irreversibly
blocks V-gated Na channels in frog muscle [23]; thus, only synaptic potentials are observed upon nerve
stimulation. Such synaptic potentials were readily blocked by 10 µM αM-MIIIJ (Figure 2C). This result
suggests that αM-MIIIJ blocked a target that directly mediated synaptic transmission; for example,
either a presynaptic voltage-gated calcium channel or postsynaptic nAChR.
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Figure 2. αM-MIIIJ blocks excitatory synaptic responses but not action potentials in X. laevis longitudinal
pectoralis (LP) muscle. Extracellular recording from adult muscle was performed as described in
Methods. Graphs plot peak amplitudes of responses versus time, where presence of αM-MIIIJ is
represented by black bar above each plot and insets show representative traces at the enumerated time
points. Arrows in insets of panels A and C show when stimulus was applied. A and B. Muscle action
potentials in response to indirect (A) and direct (B) stimulation. Ten µM αM-MIIIJ completely blocked
action potentials evoked by nerve stimulation (A); in contrast, a five-times higher concentration of
αM-MIIIJ had essentially no effect on action potentials evoked by direct stimulation (B). As a positive
control, µ-PIIIA (10 µM), a conotoxin that irreversibly inhibits muscle V-gated Na channels, completely
blocked action potentials within 10 min. (flat dashed trace of panel B’s inset). C. Motor-nerve
stimulation evoked synaptic responses (without confounding muscle action potentials) in muscle
preparation treated with µ-PIIIA (10 µM). The synaptic responses were reversibly blocked by 10 µM
αM-MIIIJ. Each trace in inset of panel C represents the average of ~10 responses. Results replicating
those illustrated here (i.e., complete block by toxin of nerve stimulation-evoked action potentials and
synaptic responses, and conversely no block by toxin of direct stimulation-evoked action potentials)
were obtained in three other LP muscle preparations.
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When R. pipiens muscles were tested, αM-MIIIJ did not block responses evoked by indirect
stimulation (Figure 3). The persistence of the muscle action potential (Figure 3A) meant that V-gated Na
channels were not blocked; moreover, this result also implied that the underlying synaptic response that
triggered the action potential was also insensitive to αM-MIIIJ. The latter implication was examined
more closely by looking directly at synaptic responses in muscles pre-treated with µ-PIIIA. Indeed,
synaptic potentials in R. pipiens muscle were resistant to block by αM-MIIIJ even at a 10-fold higher
concentration than that which rapidly obliterated synaptic potentials in X. laevis muscle (compare
Figure 3B with Figure 2C).
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Figure 3. Action and synaptic potentials in R. pipiens cutaneous pectoralis (CP) muscle are unaffected
by αM-MIIIJ (100 µM). Muscle preparation and recording were as described in Methods. Format of
presentation of results are as in Figure 2 (except traces in panel B were acquired with a low pass-filter
setting of 0.1, instead of 1, Hz). Indirectly-evoked action potentials (A) and synaptic responses (B) are
essentially unaffected by 100 µM αM-MIIIJ. In B, the muscle was treated with µ-PIIIA as in Figure 2C.
As a positive control, the preparation was exposed to the muscle nAChR antagonist d-tubocurare
(10 µM), which blocked within 15 min. (largely flat, dashed trace of panel B’s inset). These results
indicate that αM-MIIIJ does not block the muscle action potential in R. pipiens (like in X. laevis) muscle,
nor does αM-MIIIJ block (unlike in X. laevis) the synaptically-evoked response. Results replicating
those illustrated here (i.e., no block of either action or synaptic potentials by toxin) were obtained in
three other CP muscle preparations.
To examine whether synaptic block by αM-MIIIJ in the X. laevis preparation was pre- or
post-synaptic, intracellular recordings were made from muscles pretreated with µ-PIIIA to abolish
muscle twitches normally evoked by motor nerve stimulation. In addition, preparations were treated
with fluorescein-peanut agglutinin (f-PNA) to locate NMJs to assist in the placement of the intracellular
recording electrode and the ACh-iontophoresis electrode, as described in Methods. αM-MIIIJ blocked
nerve-stimulation evoked EPSPs (Figure 4A), spontaneous miniature EPSPs (MEPSPs, Figure 4B)
and responses to iontophoreticaly-applied ACh (Figure 4C). αM-MIIIJ blocked these responses >50%
at a concentration of 0.2 µM, and 100% at a concentration of 10 µM. Block of EPSPs, MEPSPs
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and ACh-evoked reponses was also observed at other αM-MIIIJ concentrations on separate muscle
preparations (see Figure 6). These results clearly show that αM-MIIIJ blocks nAChRs in X. laevis muscle.
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Figure 4. αM-MIIIJ blocks excitatory postsynaptic potentials (EPSPs), miniature excitatory postsynaptic
potentials (MEPSPs), and ACh-evoked postsynaptic potentials (PSPs) in X. laevis LP muscle. Intracellular
recording from juvenile muscle preparation was performed as described in Methods. All responses
were obtained contemporaneously from one muscle fiber whose resting potential ranged between
−77 to −88 mV. A–C. Time course of block by 0.2 or 10 µM αM-MIIIJ of EPSPs (A), MEPSPs (B),
and ACh-evoked PSPs (C). The pair of asterisks along the top of panel B denotes the time interval
flanke by the pair of asterisks i panel A. Insets in panel A and C show am le traces before (1) and
in the presence of 0.2 µM αM-MIIIJ (2) or 10 µM αM- IIIJ (3). Hump in falling phase of EPSPs in inset
of panel A presumably reflects the multiple innervation of the fiber. Sample traces in panel B were
obtained before (left) and in the presence of 0.2 µM αM-MIIIJ (right); each trace shows two MEPSPs,
and the calibration scale applies to both traces. No MEPSPs were discernable in the presence of 10 µM
αM-MIIIJ. Early spike of superimposed traces in inset of C is an artifact of the iontophoretic pulse.
2.5. Intracellular Recording of Synaptic Activity in Goldfish Intercostal (IC) Muscle
In view of αM-MIIIJ’s ability to paralyze goldfish as well as block nAChRs in X. laevis frog, we
examined whether the peptide also blocked nAChR function in goldfish, whose intercostal (IC) muscle
proved simple to dissect (see Section 5.6.). Spontaneous MEPSPs were readily observed regardless of
the site of penetration of th intracellular recording electrode. This is because the muscle fibers are
relatively hort (~1 mm) and have NMJs distributed all over their surface (see Figure S2B) as expected
of fish fast muscles. αM-MIIIJ (1 µM) readily blocked spontaneous MEPSPs in goldfish IC muscles
(Figure 5).
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Figure 5. αM-MIIIJ (10 µM) blocks MEPSPs in goldfish intercostal (IC) muscles. Intracellular recordings,
performed as described in Methods, were obtained successively from six muscle fibers, A through
F. Eac data point represents the mean p ak mplitude ± SD of at le st 30 events. Recordings were
made before (fibers A–C) and during (fibers C’–F) exposure to αM-MIIIJ (1 µM). After recordings from
fiber C were acquired, the bath was supplemented with a high concentr tion of αM-MIIIJ such that its
final concentration in the bath was 1 µM, and the recording recommenced (fiber C’) until the resting
potential was abruptly lost. The resting potentials (in mV) of the respective fibers fibers were as follows:
−67 (fiber A), −62 (fiber B), −92 (fiber C), −84 (fiber C’), −98 (fiber D), −65 (fiber E), and −101 (fiber F).
In fibers D–F, no discernable MEPSPs were observed above the noise and indicated the block by 1 µM
αM-MIIIJ was > 80% in each case.
αM-MIIIJ clearly blocks the ACh-mediated postsynaptic responses in both X. laevis and goldfish
muscles. The block was concentration dependent as illustrated in Figure 6, which combines the results
from different preparatio s. In the figure, there are also three binding curves for a simple bimolecular
interaction of toxin and r ceptor with an IC50 f 0.05, 0.1 o 0.2 µM (see Figure 6 legend for equation).
The potencies of αM-MII J in blocking nACh recept rs of X. laevis and goldfish muscles were similar,
with an IC50 estimated to be within about a factor of two of 0.1 µM.
Toxins 2020, 12, x FOR PEER EVIEW 8 of 29 
 
as expected of fish fast muscles. αM-MI J (1  il  locked spontaneous MEPSPs in goldfish 
IC muscles (Figure 5). 
 
Figure 5. αM-MIIIJ (10 μM) blocks EPSPs in g ldfish intercostal (IC) muscles. Intracellular 
recor ings, perfo med as described in M thods, were obtained successively from six muscle f bers, A 
through F. Each data po nt represents th  mean peak amplitude ± SD of at least 30 ev nts. Recordings 
we  made before (fibers A–C) and during (fibers C’–F) exposure to αM-MIIIJ (1 μM). After 
recordings from fiber C were acquired, the bath was suppleme ted with a high concentration of αM-
MIIIJ such that its final concentration in the bath was 1 μM, and the recording recommenced (fiber 
C’) until the resting potential was abruptly lost. The resting potentials (in mV) of the respective fibers 
fibers were as follows: −67 (fiber A), −62 (fiber B), −92 (fiber C), −84 (fiber C’), −98 (fiber D), −65 (fiber 
E), and −101 (fiber F). In fibers D–F, no discernable MEPSPs were observed above the noise and 
indicated the block by 1 μM αM-MIIIJ was > 80% in each case. 
αM-MIIIJ clearly blocks the ACh-mediated postsynaptic responses in both X. laevis and goldfish 
muscles. The block was concentration dependent as illustrated in Figure 6, which combines the 
results from different preparations. In the figure, there are also three binding curves for a simple 
bimolecular interaction of toxin and receptor with an IC50 of 0.05, 0.1 or 0.2 μM (see Figure 6 legend 
for equation). The potencies of αM-MIIIJ in blocking nACh receptors of X. laevis and goldfish muscles 
were similar, with an IC50 estimated to be within about a factor of two of 0.1 μM. 
 
Figure 6. Concentration-dependent block by αM-MIIIJ of synaptically- and ACh-evoked responses at 
frog and fish NMJs. Plot summarizing results with different concentrations of αM-MIIIJ from 
experiments of the sort illustrated in Figure 4; Figure 5. Percentage block of: EPSPs in X. laevis LP 
(circles, 2); spontaneous MEPSPs in X. laevis LP (squares, 4) and goldfish IC (diamond, which denotes 
the minimum block of 80% by 1 μM peptide in fibers D, E, and F in Figure 5); a d ACh-evoked 
responses in X. laevis LP (triangles, 2). Each point represents one measurement. Block of EPSPs were 
not corrected for non-linear summation [24] and are therefore minimum estimates. Lines are curves 
of the Langmuir adsorption isotherm, % Block = 100%/{1 + (IC50/[Toxin])}, where [Toxin] is αM-MIIIJ 
0
20
40
60
80
100
0.001 0.01 0.1 1 10 100
% 
Blo
ck
 
[αM-MIIIJ] (μM)
Figure 6. Concentration-depe l ck by αM-M IIJ of synaptically- and ACh-evok d responses
at fi . Plot summarizing results with different concentrations of αM-MIIIJ from
experiments of the sort illustrated in Figure 4; i ercentage block of: EPSPs in X. laevis LP
(cir les, 2); spontaneous MEPSPs in X. laevis , ) and goldfish IC (diamond, which denotes
the minimum block of 80% by 1 µM pepti i fi , , and F in Figure 5); and ACh-evoked
responses in X. laevis LP (triangles, 2). Eac i t re rese ts one easurement. Block of E SPs were
not corrected for non-linear sum ation [24] and are therefore minimum estimates. Lines are curves of
the Langmuir adsorption isotherm, % Block = 100%/{1 + (IC50/[Toxin])}, where [Toxin] is αM-MIIIJ
concentration, and IC50 = 0.1, 0.05 or 0.2 µM (central bold-dotted line and flanking dashed lines,
respectively). Experimental points lie close to or between the dashed lines and suggest an aggregate
IC50 within a factor of about two of 0.1 µM.
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2.6. αM-MIIIJ Reversibly Blocks ACh-Gated Currents (IACh) of Zebrafish-Muscle nAChRs Exogenously
Expressed in X. laevis Oocytes
Three combinations of nAChRs subunits expressed in zebrafish muscle have been identified:
αβδγ (embryonic fibers), αβδε (larval and adult fast fibers), and αβδ (slow fibers) [25] (see also [26,27]).
The susceptibilities of these nAChRs to αM-MIIIJ were examined in two-electrode voltage-clamped
oocytes expressing each of the three combinations of zebrafish subunits, and the ACh-gated currents
(IACh) were measured to monitor the function of the nAChRs. αM-MIIIJ blocked the IACh of all three
subunit combinations with IC50s in the range of 50 nM (Figure 7, IC50 values are in Table 2). These
results are consistent with what we observed with nAChRs endogenously expressed in muscles of
Xenopus frog and goldfish (Figure 6).
Toxins 2020, 12, x FOR PEER REVIEW 9 of 29 
 
concentration, and IC50 = 0.1, 0.05 or 0.2 μM (central bold-dotted line and flanking dashed lines, 
respectively). Experimental points lie close to or between the dashed lines and suggest an aggregate 
IC50 within a factor of about two of 0.1 μM. 
2.6. αM-MIIIJ Reversibly Blocks ACh-Gated Currents (IACh) of Zebrafish-Muscle nAChRs Exogenously 
Expressed in X. laevis Oocytes 
Three combinations of nAChRs subunits expressed in zebrafish muscle have been identified: 
αβδγ (embryonic fibers), αβδε (larval and adult fast fibers), and αβδ (slow fibers) [25] (see also 
[26,27]). The susceptibilities of these nAChRs to αM-MIIIJ were examined in two-electrode voltage-
clamped oocytes expressing each of the three combinations of zebrafish subunits, and the ACh-gated 
currents (IACh) were measured to monitor the function of the nAChRs. αM-MIIIJ blocked the IACh of 
all three subunit combinations with IC50s in the range of 50 nM (Figure 7, IC50 values are in Table 2). 
Thes  result  are consistent with what we observed with nAChRs endogenously expressed in 
muscles of Xenopus frog and goldfish (Figure 6). 
 
Figure 7. αM-MIIIJ blocks ACh-gated currents (IACh) of voltage-clamped X. laevis oocytes exogenously 
expressing zebrafish nAChRs. Expression of nAChRs, induction of IACh in voltage-clamped oocytes, 
and toxin application and analysis of consequent effects were performed as described in Methods. 
Concentration-dependent block by αM-MIIIJ of three combinations of zebrafish nAChR subunits are 
plotted (αβδε, closed circles; αβδγ, open circles; and αβδ, open squares). Each data point represents 
mean ± SE (n = 3 or 4 oocytes). Solid line represents best-fit curve of the data to the Langmuir 
adsorption isotherm (see Table 2 for IC50s). Inset illustrates example IACh traces from an oocyte 
expressing the αβδ-subunit combination before (control), immediately after a 5-min. exposure to 330 
nM αM-MIIJ, and following peptide washout at 1-min. intervals; duration of each trace is 4 sec. The 
block by αM-MIIIJ was readily reversible.  
Table 2. IC50s of αM-MIIIJ and α-EI on nAChRs expressed in X. laevis oocytes. 1. 
nAChR 2 αM-MIIIJ α-EI 
zαβδ 0.033 (0.023–0.048) 3 0.073 (0.045–0.118) 4 
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zαβδε 0.058 (0.040–0.085) 3 0.058 (0.039–0.087) 4 
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mαβδγ 44.4 (25.4–77.5) 6 N.A. 
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rα4β2 >>10 8 N. A. 9 
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Figure 7. αM-MIIIJ blocks ACh-gated currents (IACh) of voltage-clamped X. laevis oocytes exogenously
expressing zebrafish nAChRs. Expression of nAChRs, induction of IACh in voltage-clamped oocytes,
and toxin application and analysis of consequent effects were performed as described in Methods.
Concentration-dependent block by αM-MIIIJ f t ree combinations of zebrafish nAChR subunits are
plotted (αβδε, closed cir les; αβδγ, open circl βδ, open squares). Each data point represents
mean± SE (n = 3 or 4 o cytes). Solid line repr sents b s -fit curve of the da a to the Langmuir adso ption
isotherm (see Table 2 for IC50s). Inset illustrates example IACh traces from an oocyte expressing the
αβδ-subunit combination before (control), immediately after a 5-min. exposure to 330 nM αM-MIIJ,
and following peptide washout at 1-min. intervals; duration of each trace is 4 sec. The block by
αM-MIIIJ was readily reversible.
Table 2. IC50s of αM-MIIIJ and α-EI on nAChRs expressed in X. laevis oocytes. 1.
nAChR 2 αM-MIIIJ α-EI
zαβδ 0.033 (0.023–0.048) 3 0.073 (0.045–0.118) 4
zαβδγ 0.061 (0.049–0.076) 3 0.103 (0.069–0.155) 4
zαβδε 0. 58 (0.040–0.085) 3 0.058 (0. 39–0.087) 4
zαβε 0.034 (0.022–0.053) 5 N. A.
mαβδγ 44.4 (25.4–77.5) 6 N.A.
mαβδε 3.6 (2.6–4.9) 6 N. A.
hαβδγ 19.6 (13.8–27.7) 6 N. A. 7
hαβδε 4.1 (2.9–5.9) 6 N. A.
hα9α10 >>10 8 N. A.
rα4β2 >>10 8 N. A. 9
rα3β4 >>10 8 N. A. 10
1 IC50 value in µM, 95% C.I. in parentheses. N.A. indicates not tested or not available (but see related information in
enumerated footnote). 2 Prefix: z, zebrafish; m, mouse; h, human; r, rat. Greek letters: combination of nAChR-subunit
cRNAs injected into a given oocyte. 3 from Figure 7. 4 see Figure 9. 5 see Figure 8A. 6 see Figure 11. 7 IC50 = 0.187
± 0.043 µM (mean ± S.E.) from patch-clamped human rhabdomyocarcoma cell line TE671 expressing hαβγδ [28].
8 No block observed with 10 µM, the highest αM-MIIIJ concentration tested (n = 3 oocytes). 9 IACh in patch-clamped
HEK293 line expressing hα4β2 nAChRs was 60% blocked by 10 µM α-EI [28]. 10 IACh in patch-clamped HEK293
line expressing hα3β4 nAChRs was 90% blocked by 10 µM α-EI [28].
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nAChRs comprised of only three different subunit combinations (αβγ, αβδ, and αβε receptors)
are not endogenously expressed except in zebrafish, which express αβδ nAChRs as described above.
Such combinations of mammalian nAChR subunits have been exogenously expressed in X. laevis
oocytes to help identify the binding sites of competitive nAChR antagonists (e.g., [29]). Toward that
end, we also tried to functionally express zebrafish αβγ- and αβε-receptor combinations in oocytes.
Thus far, we have successfully expressed only the latter and characterized its block by αM-MIIIJ
(Figure 8A,B).
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The reversibility of αM-MIIIJ’s block of IACh during its washout from αβδε and αβε nAChRs was 
relatively slow (koff of 0.80 min−1 (95% C.I. of 0.7–0.9) for αβε, and 0.76 min−1 (95% C.I. of 0.4–1.2) for 
αβδε, Figure 8B and C). For subunit combinations lacking the ε-subunit (αβδ and αβδγ), however, 
IACh recovered almost completely within a minute of αM-MIIIJ washout (e.g., Figure 7 inset) with a 
koff of 2.4 min−1 (95% C.I. of 0.0–5.2) for αβδγ, and 2.5 min−1 (95% C.I. of 1.1–3.9) for αβδ (data were 
the aggregate of open circles in Figure 9A and D, and C and F, respectively). 
Figure 8. αM-MIIIA block of αβε nAChR (A), and washout kinetics from αβε AChR (B) and αβδε
nAChR (C). These experiments were done essentially as in Figure 7. A.αM-MIIIJ concentration–response
curve for block of αβε nAChR (see Table 2 for IC50). The data points follow a trajectory steeper than
their fit to a Langmuir isotherm (solid curve), the significance of which remains to be determined.
B, C. αM-MIIIJ washout curves from αβε (B) and αβδε (C) nAChRs. Solid line is the best-fit
single-exponential curve with a koff of 0.80 min−1 (95% C.I. of 0.7–0.9) for αβε, and 0.76 min−1 (95% C.I.
of 0.4–1.2) for αβδε. Data points represent mean ± S.E. (n = 3 for panels A and B; and n = 6 for panel C,
from aggregate of open circles in Figure 9B,E below).
The reversibility of αM-MIIIJ’s block of IACh during its washout from αβδε and αβε nAChRs was
relatively slow (koff of 0.80 min−1 (95% C.I. of 0.7–0.9) for αβε, and 0.76 min−1 (95% C.I. of 0.4–1.2) for
αβδε, Figure 8B,C). For subunit combinations lacking the ε-subunit (αβδ and αβδγ), however, IACh
recovered almost completely within a minute of αM-MIIIJ washout (e.g., Figure 7 inset) with a koff
of 2.4 min−1 (95% C.I. of 0.0–5.2) for αβδγ, and 2.5 min−1 (95% C.I. of 1.1–3.9) for αβδ (data were the
aggregate of open circles in Figure 9A,D and C,F, respectively).
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Figure 9. αM-MIIIJ (10 µM) protects zebrafish nAChRs against slowly-reversible block by α-EI
and α-bungarotoxin (α-BgTX). ACh-gated currents from oocytes expressing zebrafish nAChRs were
obtained as described in Methods. A given oocyte was first exposed to 10 µM αM-MIIIJ for 10 min. in
a static bath, then perfused to observe the time course of recovery from block (open circles). The oocyte
was then exposed again to 10 µM αM-MIIIJ for 5 min. in a static bath, after which the bath was
supplemented with either 1 µM α-EI (open squares in panels A, B, and C) or 10 µg/mL α-BgTX (open
squares in panels D, E, and F) and allowed to sit for another 5 min before the bath perfusion was
recommenced. Finally, in a separate experiment, a given oocyte was exposed to either 1 µM α-EI alone
(panels A, B, and C) or 10 µg/mL of α-BgTX alone (panels D, E, and F) for 5-min in a static bath before
bath perfusion was recommenced (solid triangles). The time courses of recovery from block during the
perfusion following the static-bath exposure to toxin(s) are plotted. Recovery from block following
exposure to α-EI alone or α-BgTX alone was very slow in all panels (solid triangles). Furthermore, in
all instances, except panel D, pre- and concurrent exposure to αM-MIIIJ prevented persistent block
by α-EI and α-BgTX (as evident from similarity of time courses curves denoted by open circles and
open squares). The divergent open-circle and open-square curves in panel D indicate that αM-MIIIJ
only partially protected the αβδγ receptor against block by α-BgTX. α-BgTX use in these experiments
was derivatized with tetramethylrhodamine (same stock solution as that used in fluorescence imaging
experiments described below).
2.7. αM-MIIIJ Protects Zebrafish nAChRs Against A-Bungarotoxin (α-BgTX) and A-Conotoxin EI (α-EI)
To examine the mechanism by which αM-MIIIJ blocks the zebrafish nAChRs, we performed
competition-blocking experiments bet een αM-MIIIJ and two other nAChR antagonists: α-BgTX an
α-EI. IACh of all three subunit com inatio s were irreversibly blocked by α-BgTX (see Figure 9D–F)
and slowly-reversibly blocked by α-EI (Figure 10 and its inset, also see Figure 9A–C).
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zebrafish nAChRs tested (αβγδ, αβδε, and αβδ) was rapidly reversed upon toxin washout (compare
circles and squares in Figure 9A–C). The same was observed when α-BgTX (10 µg/mL) was used
instead of α-EI with αβδ and αβδε nAChRs (Figure 9E,F), which indicates that these two nAChRs
were largely protected by αM-MIIIJ against block by α-BgTX. However, for αβδγ nAChRs, αM-MIIIJ
provided only partial protection against α-BgTX (Figure 9D).
2.8. αM-MIIIJ Blocks Indirectly-Evoked Mouse Muscle Action Potentials and Exogenously-Expressed Mouse
and Human Muscle nAChRs
As described above, αM-MIIIJ failed to paralyze mice in in-vivo assays, and we wondered whether
this was a consequence of inadequate dosage or possible pharmacokinetic effects. Thus, e teste
the peptide on an isolated mouse muscle preparation and observed that 10 µM αM-MIIIJ blocked
muscle action potentials evoked by motor-nerve stimulation (Figure 11). To more quantitatively
assess the pharmacology of αM-MIIIJ, we tested the peptide on mammalian muscle nAChRs
exogenously-expressed in X. laevis oocytes. At micromolar concentrations, αM-MIIIJ blocked IACh of
αβδγ and αβδε nAChRs from both mouse and human (Figure 12). We conclude that αM-MIIIJ blocks
both endogenous and exogenously-expressed mam alian muscle nAChRs, albeit with considerably
less potency than muscle nAChRs of fish, the natural prey of C. magus.
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Figure 11. αM-MIIIJ (10 µM) blocks neuromuscular transmission in mouse muscle. Extracellular
recording of the mouse levator auris longus (LAL) muscle’s action potential evoked by indirect
stimulation was performed as described in Methods. Plot of peak (negative) amplitude of muscle
action potential as a function of time before, during exposure to 10 µM αM-MIIIJ (indicated by black
bar), and after toxin washout. Inset shows example traces of the extracellularly-recorded action
potential before (trace 1), during block by toxin (trace 2) and after washout (trace 3), with trace numbers
corresponding to times indicated in the main plot. The results are consistent with a low-potency block
of mouse muscle nAChRs; direct evidence for this is illustrated in Figure 12.
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Figure 12. αM-MIIIJ blocks mammalian muscle nAChRs with low potencies. Oocytes expressing
nAChRs from human (A) and mouse (B) were voltage-clamped and exposed toαM-MIIIJ as described in
Methods. Concentration–response curves for the block by αM-MIIIJ of IACh in oocytes expressing αβδγ
(open circles) or αβδε (closed circles) subunits. Solid lines represent best-fit curves to the Langmuir
isotherm (see Table 2 for IC50s).
2.9. Lack of Effects of αM-MIIIJ on Neuronal nAChRs
To examine αM-MIIIJ’s selectivity for muscle over neuronal nAChRs, we tested αM-MIIIJ on the
following exogenously-expre d neuronal nAChRs: α3β4 (rat), α4β2 (rat), α9α10 (human). αM-MIIIJ
(10 µM, the highest concentration tested) f iled to block IACh of any of these receptors (T ble 2).
2.10. Imaging the Binding of Fluorescently-Labeled α-BgTX at Frog NMJs
To further investigate αM-MIIIJ’s mechanism of action, we examined the manner in which the
peptide affected α-BgTX binding. Tetramethylrhodamine conjugated α-bungarotoxin (TMR α-BgTX)
readily stained NMJs of both X. laevis LP and R. pipiens CP muscles (Figure 13C,F, respectively). Muscles
were pre-treate with fluorescein peanut agglutinin (f-PNA) so the progress of TMR α-BgTX binding at
a given NMJ could be tracked (Figure 13B,E). In control experiments (i.e., in the absence of αM-MIIIJ),
the binding of 1 µg/mL TMR α-BgTX to the X. laevis NMJ leveled off within about 20 min (Figure 13A,
muscle I, squares). Similar results were obtained with R. pipiens CP preparations (cf., Figure 13F).
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Figure 13. αM-MIIIJ (10 µM) inhibits binding of TMR α-BgTX at neuromuscular junctions of X. laevis LP
muscl . Preparation of muscles, image acquisition, and quantification f fl orescence were performed
as describ d in Methods. A. Two preparations, M cle I and Muscle II, were stained with f-PNA so
locations of NMJs ould be identified as described in Methods. In Muscle I, the NFR bathing the muscle
was replaced (at t = 10′) with 1 µg/mL TMR α-BgTX, and the N J was periodica ly imaged while its
staining ensued until a steady state as achieved (squares). Muscle II was treated with 10 µM αM-MIIIJ
(at t = 0) for 10-min. before it was exposed o 1 µg/mL TMR α-BgTX + 10 µM αM-MIIIJ, after which the
endplate was periodically imaged for 30-min. (gray circles). Then the solution bathing muscle II was
removed and r served, and the muscle rinsed. After ~90- in., Muscle II was exposed to 1 µg/mL TMR
α-BgTX alone while the NMJ was periodically imaged until the fluorescence reached st ady state (black
circles). The steady-state level of fluorescence v ried from one NMJ to the next, so the fluorescence
values at each endplate were norm lized to the value obtain d at stea y state (at t ≈ 30′ for Muscle I
and t ≈ 140′ for Muscle II). Each data point represents the mean ± SD from 9 to 12 regions of interest
(ROIs; see rectangle in panel C) obtained along the NMJ. Presence of αM-MIIIJ clearly interfered with
α-BgTX binding. B and E. f-PNA staining of an NMJ from X. laevis LP muscle (B) and R. pipiens CP
muscle (E). C and F. TMR α-BgTX staining of X. laevis LP muscle (C) and R. pipiens CP muscle (F). Here,
the CP muscle was treated with the reserved T R α-BgTX + αM-MIIIJ solution removed from Muscle
II; nevertheless, strong TMR staining is clearly evident. D and G. Overlays of images in panels B and C
(D) and panels E and F (G). H. Fluorescence profile from the ROI in panel C (see rectangle therein).
Calibration bar (20 µm, white line) in G applies to panels B through G. Presence of αM-MIIIJ clearly
inhibited the binding of TMR α-BgTX at the NMJ of the X. laevis LP muscle but not at that of the R.
pipiens CP muscle.
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In contrast, when 10 µM αM-MIIIJ was present, very little binding of TMR α-BgTX to the X. laevis
NMJ was observed even after 30 min (Figure 13A, muscle II, gray circles). Muscle II was washed for >
60 min. (to allow the αM-MIIIJ to unbind) and then exposed to TMR α-BgTX alone. This time, TMR
α-BgTX readily bound and reached steady state in about 20 min (Figure 13A, muscle II, black circles),
just as was observed for muscle I (Figure 13A, squares).
As a positive control, the ‘used’ mixture of α-BgTX + αM-MIIIJ to which muscle II had been
exposed was applied to a ‘naïve’ R. pipiens CP preparation for about 10-min and imaged. The R.
pipiens NMJs were robustly stained by TMR α-BgTX (Figure 13F), consistent with our results indicating
that synaptic responses of R. pipiens CP muscles, unlike those of X. laevis LP muscles, are relatively
resistant to block by αM-MIIIJ (Figure 3B). More to the point, these results also showed that: a)
αM-MIIIJ had not somehow inactivated the α-BgTX to produce the protection represented by the
gray circles in Figure 13A; and b) αM-MIIIJ’s association with nAChRs is reversible, consistent with
electrophysiological results (e.g., Figure 2C, Figure 7 inset, Figures 8 and 9).
2.11. Imaging the Binding of Fluorescently-Labeled α-BgTX at NMJs of Goldfish IC Muscle
We next examined whether αM-MIIIJ interfered with the binding of TMR α-BgTX to goldfish
NMJs. We found that f-PNA could not be used as a marker for goldfish NMJs; so, goldfish IC muscle
preparations were treated in two ways. Treatments involved exposure to TMR α-BgTX (1 µg/mL) for
10 min in the presence of αM-MIIIJ (10 µM, Treatment I) or in the absence of αM-MIIIJ (Treatment
II). Preparations were then rinsed and imaged. Minimal TMR α-BgTX staining was observed in the
presence of αM-MIIIJ (Figure S2A, Treatment I). On the other hand, robust staining was observed in
the absence of the conotoxin (Figure S2A, Treatment II). These results demonstrate that, just as with X.
laevis LP muscles, αM-MIIIJ protects goldfish IC muscles against α-BgTX binding.
2.12. Binding of Fluorescently-Labeled α-BgTX at Zebrafish NMJs
Goldfish intercostal muscle fibers have NMJs distributed over their entire surface (Figure
S2B) and are therefore presumably fast muscles. To confirm our functional results, obtained with
exogenously-expressed zebrafish fast and slow muscle nAChRs, on endogenous channels at the level
of toxin binding, we exploited the fact that while NMJs of fast fibers are widely distributed, NMJs
of slow fibers are largely confined to their myoseptal ends [30]. Toward this end, we performed
competition-binding studies with fluorescently-labeled α-BgTX on a preparation from larval zebrafish,
whose skin is relatively transparent and whose muscles have both fast and slow fibers, as described in
Methods (see also Figure S3B).
This experiment employed Alexa488 α-BgTX (which fluoresces green) in addition to TMR α-BgTX,
and it was performed in three phases. In phase 1, the preparation was lightly treated with TMR α-BgTX
to provide an irreversible marker for NMJs. In the subsequent two phases, the preparation was treated
with Alexa488 α-BgTX, first in the presence of αM-MIIIJ (phase 2), then in the absence of αM-MIIIJ
(phase 3), with washing after each phase followed by imaging. About an hour elapsed between the
end of phase 2 and the start of phase 3. The mean values of green (Alexa488 α-BgTX) fluorescence at
NMJs of both fast and slow fibers were lower after Phase 2 than after Phase 3, showing that αM-MIIIJ
(10 µM) inhibited α-BgTX binding to both types of muscle fibers (Figure S3A).
Taken together, the results of our electrophysiological and fluorescence-imaging experiments
demonstrate that αM-MIIIJ avidly targets nAChRs at the NMJs of frog (X. laevis) and fish (C. auratus
and D. rerio).
3. Discussion
3.1. αM-MIIIJ Uncovers a New Family of Muscle nAChR-Targeting Conotoxins
αM-MIIIJ and related sequences from other fish-hunters form a new class within the large
M-superfamily of conotoxins. M-superfamily toxins are highly diverse and are found in nearly all cone
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snail species studied to date where they are known to exert various functions [21]. Two well-studied
classes within the M-superfamily are µ-conotoxins which target voltage-gated Na channels [31] and
ψ-conotoxins which block muscle nAChR without competing with the bungarotoxin binding site [20].
While these toxins all belong to the M-superfamily and share the same cysteine framework with
αM-MIIIJ, their primary amino acid sequences are highly divergent (Figure 1A, bottom alignments).
In contrast, αM-MIIIJ and related sequences from the Pionoconus clade are highly conserved and share
a number of identical residues (Figure 1A, black arrowheads above top alignment). We demonstrate
here that αM-MIIIJ blocks muscle nAChR and propose that the αM-MIIIJ-like peptides are also
antagonists of muscle nAChR. Future functional studies are needed to investigate this hypothesis.
3.2. αM-MIIIJ Blocks Muscle nAChRs of X. laevis Frogs
Three ion-channel targets of known paralytic conotoxins are presynaptic V-gated Ca channels,
postsynaptic nAChRs, and skeletal muscle V-gated Na channels (Table 1). With regard to X. laevis
muscle, αM-MIIIJ did not block directly-evoked action potentials (Figure 2B), thus ruling out muscle
Na channels as a target of the peptide. During exposure to αM-MIIIJ, no indication of quantized block
(Figure 4A) or sparing of MEPSPs (Figure 4B) was observed, unlike the effects ofω-GVIA, which blocks
presynaptic Ca channels at the frog NMJ [32]. Likewise, during the exposure to αM-MIIIJ, the block of
EPSPs progressed smoothly with no major decrements (Figure 4A) that would suggest conduction
failure in the motor axon; thus, we conclude that the peptide did not block action potentials (and by
extension, V-gated Na channels) in the nerve. In contrast, αM-MIIIJ blocked the muscle’s response to
ionotophoretically- (i.e., exogenously-) applied ACh (Figure 4C), clearly demonstrating that αM-MIIIJ
is an antagonist of nAChRs.
3.3. αM-MIIIJ Blocks nAChRs of Goldfish Muscle
αM-MIIIJ is from a fish-hunting cone (see Introduction). Thus, the observation that the peptide
paralyzes goldfish (Table S1) was not unexpected. With the knowledge that nAChRs were a target of
αM-MIIIJ, we next focused our attention on nAChRs of goldfish muscle. αM-MIIIJ clearly blocked
spontaneous miniature synaptic potentials in goldfish intercostal muscles (Figure 5).
3.4. αM-MIIIJ Blocks IACh of Zebrafish-Muscle nAChRs Exogenously Expressed in X. laevis Oocytes
The nAChR subunit compositions of fast and slow muscles of both larval and older zebrafish
have been identified as αβδε and αβδ, respectively [25]. αM-MIIIJ blocked nAChRs composed of both
subunit combinations (Figure 7). For good measure, we also tested the embryonic (αβδγ) combination
and found it was also blocked by αM-MIIIJ (Figure 7). All three subunit combinations yielded αM-MIIIJ
concentration–response curves with similar IC50s and slopes (Figure 7), with the αβδ combination
having an affinity about a factor of two higher than that of the other two (Table 2). The αβε-subunit
combination would be expected to have a subunit-stoichiometry for the pentameric nAChR of α2β1ε2,
with two α/ε interfaces, while the αβδε-combination would have one α/ε interface (and one α/δ
interface). The IC50 of αM-MIIIJ for αβε was similar to that for αβδ (Table 2). It might be noted
that for a receptor with two binding sites with identical affinity for a toxin, the IC50 for functional
block of the receptor would be the square-root of the affinity constant of the sites [33]. These results
suggest that αM-MIIIJ binds with about equal avidity to both the α/δ and α/ε interfaces, which is
consistent with our αBgTX-competition experiments (Figure 9E,F). αM-MIIIJ provided αβδγ nAChRs
only-partial protection against α-BgTX (Figure 9D), suggesting that αM-MIIIJ had a lower affinity for
the α/γ-interface than the α/δ- and α/ε-interfaces; alternatively, α-BgTX bound to the α/γ interface
more quickly than to either the α/δ- or α/ε-interfaces. This issue may be resolved when functional
expression of αβγ nAChRs is achieved.
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3.5. αM-MIIIJ Inhibits the Binding of α-BgTX to Frog and Fish NMJs
Fluorescently-tagged α-BgTX has long served as an extremely useful marker for nAChRs since
the initial synthesis of TMR α-BgTX and its use to stain R. pipiens and X. laevis NMJs [34]. We observed
that αM-MIIIJ inhibited the binding of α-BgTX at the NMJs of X. laevis (Figure 13A), goldfish (Figure
S2A) and zebrafish (Figure S3A). As might be expected, αM-MIIIJ did not interfere with the binding of
α-BgTX at the NMJ of R. pipiens (Figure 13F).
It is intriguing that αM-MIIIJ blocks muscle nAChRs of X. laevis but not those of R. pipiens. This
result is consistent with our observations that αM-MIIIJ protects nAChRs of X. laevis (Figure 13A), but
not those of R. pipiens (Figure 13F), againstα-BgTX. It would be interesting to explore the underpinnings
of the difference at the molecular level. It might be noted that neuronal nAChRs of closely-related frogs
can have different sequences, as was observed where the driving force for variation involved resistance
to epibatidine, a nAChR-targeting neurotoxic alkaloid used by some frogs for chemical defense [35].
3.6. Possible Rationale for the Presence of both a-MI and αM-MIIIJ in C. magus Venom
Aside from α-MI and αM-MIIIJ, each of the C. magus venom peptides listed in Table 1 has a distinct
ion-channel target. α-MII was much more potent than α-MI in blocking synaptic transmission in
sympathetic ganglia of frog, which led us to speculate that the role of α-MII in C. magus venom is to
interfere with the flight-or-fight response of fish prey [36], in contrast to the role of α-MI, which is to
immobilize fish prey.
α-MI is potent in paralyzing mice, and in view of its sequence homology to α-GI, α-GIA and α-GII
(Table 3), which block muscle nAChRs [37], α-MI was presumed to also block muscle nAChRs [8].
Indeed, competition-binding experiments with [125I]α-BgTX revealed that α-MI blocks muscle nAChRs
by binding with high affinity to the α/γ (of Torpedo) and α/δ (of mouse) ACh-binding sites of the
receptor [22,38]. α-MIC, the most recently characterized α-MI congener, has a similar LD50 against
fish (Xiphophorous helleri) as that of α-MI; furthermore, α-MIC competitively inhibits the binding of
[3H]epibatidine to the muscle subtype of nAChRs from Torpedo californica with a Ki similar to that of
α-MI [39].
Table 3. Peptides of fish-hunting Conus that block nAChRs.1. Cysteine are in bold
Peptide 2 Sequence 3 Reference
α(3/5)
α-GI ECCNPACGRHYSC# Gray 1981 [37]
α-GIA ECCNPACGRHYSCGK# Gray 1981 [37]
α-GIB ECCNPACGRHYSCKG# McIntosh 2002 [40]
α-GII ECCHPACGKHFSC# Gray 1981 [37]
α-MI GRCCHPACGKNYSC# McIntosh 1982 [8]
α-MIA DGRCCHPACAKHFNC# McIntosh 2002 [40]
α-MIB NGRCCHPACGKNYSC# McIntosh 2002 [40]
α-MIC CCHPACGKNYSC# Kapono 2013 [39]
α-SI ICCNPACGPKYSC# Zafaralla 1988 [41]
α-SIA YCCHPACGKNFDC# Myers 1991 [42]
α-SII GCCCNPACGPNYGCGTSCS Ramilo 1992 [43]
α-Ac1.1a NGRCCHPACGKHFNC# Liu 2007 [44]
α-Ac1.1b NGRCCHPACGKHFSC# Liu 2007 [44]
α-CnIA GRCCHPACGKYYSC# Favreau 1999 [45]
α-CnIB CCHPACGKYYSC# Favreau 1999 [45]
α(4/7)
α-EI RDOCCYHPTCNMSNPQIC# Martinez 1995 [22]
α-MII† GCCSNPVCHLEHSNLC# Cartier 1996 [9]
α-GIC† GCCSHPACAGNNQHIC# McIntosh 2002 [40]
α-GID† IRDγCCSNPACRVNNOHVC Nicke 2003 [46]
α-PIA† RDPCCSNPVCTVHNPQIC# Dowell 2003 [47]
α-PeIA† GCCSHPACSVNHPELC# McIntosh 2005 [48]
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Table 3. Peptides of fish-hunting Conus that block nAChRs.1. Cysteine are in bold
Peptide 2 Sequence 3 Reference
α(4/4)
α-BuIA† GCCSTPPCAVLYC# Azam 2005 [49]
α-PIB ZSOGCCWNPACVKNRC# Lopez-Vera 2007 [50]
α-EIIA ZTOGCCWNPACVKNRC# Quinton 2013 [51]
αALong
αA-PIVA GCCGSYONAACHOCSCKDROSYCGQ# Hopkins 1995 [52]
αA-EIVA GCCGPYONAACHOCGCKVGROOYCDROSGG# Jacobsen 1997 [33]
αA-EIVB GCCGKYONAACHOCGCTVGROOYCDROSGG# Jacobsen 1997 [33]
αAShort
αA-OIVA CCGVONAACHOCVCKNTC# Teichert 2004 [53]
αA-OIVB CCGVONAACPOCVCNKTCG# Teichert 2005b [54]
αA-PeIVA CCGVONAACHOCVCTGKC Teichert 2006 [55]
αS
αS-RVIIA KCNFDKCKGTGVYNCGγSCSCγGLHSCRCTY
NIGSMKSGCACICTYY Teichert 2005a [54]
αS-GVIIIB† SGSTCTCFTSTNCQGSCECLSPPGCYCSNN
GIRQRGCSCTCPGT# Christensen 2015 [56]
αC
αC-PrXA TYGIYDAKPOFSCAGLRGGCVLPONLROKFKE# Jimenez 2007 [29]
αM
ψ-PIIIE HOOCCLYGKCRRYOGCSSASCCQR# Shon 1997 [20]
ψ-PIIIF GOOCCLYGSCROFOGCYNALCCRK# Van Wagoner 2003 [57]
ψ-Pr3e AARCCTYHGSCLKEKCRRKYCC# Lluisma 2008 [18]
αM-MIIIJ ZKCCSGGSCPLYFRDRLICPCC This report
1 All peptides listed block muscle nAChRs except for the following seven that are tagged with a dagger symbol
(†): α-MII, α-GIC, α-GID, α-PIA, α-PeIA, α-BuIA, and αS-GVIIIB, which preferentially block neuronal nAChRs
over muscle nAChRs for exogenously expressed mammalian receptors (e.g., α6β3β2 and α3β2 for α-MII; α3β2 for
α-GIC, and α6β3β2 for α-PIA). 2 First letter following the hyphen indicates Conus species, as follows: Ac, achatinus;
E, ermineus; G, geographus; M, magus; O, obscurus; P, purpurascens; Pe, pergrandis; Pr, parius; R, radiatus; and S, striatus.
# indicates C-terminal amidation; O, hydroxyproline; Z, pyroglutamate; γ, gamma-carboxyglutamate.
The disparity between the structures of α-MI and αM-MIIIJ raises the question as to whether
αM-MIIIJ binds to the same site of muscle nAChRs as does α-MI. Our results showing that 10 µM
αM-MIIIJ almost completely inhibits α-BgTX binding (Figure 13A, Figures S2A and S3A) suggest that at
this concentration αM-MIIIJ likely occludes both α-BgTX-binding sites of a given nAChR. These results
are consistent with the protection αM-MIIIJ affords the zebrafish nAChR subunit combinations αβδ
(slow-fiber nAChRs) and αβδε (‘adult’ fast fiber) against block of their IACh by α-BgTX (Figure 9E,F).
The only-partial protection 10 µMαM-MIIIJ afforded theαβδγ nAChR subunit combination (Figure 9D)
suggests that α-BgTX may bind more quickly to the α/γ interface than to either the α/δ or α/ε interfaces.
Alternatively, αM-MIIIJ may have a lower affinity for the α/γ interface than for either the α/δ or α/ε
interfaces. We did not perform any experiments on embryonic zebrafish muscle, which express αβδγ
nAChRs. In view of our electrophysiological results of Figure 9D, we predict that αM-MIIIJ would
only partially protect NMJs of embryonic muscle against staining by fluorescent α-BgTX.
In the discussion above, we assumed that αM-MIIIJ interacts directly with each of the
two ACh-binding (or orthosteric) sites of the receptor. A far less parsimonious possibility is that
αM-MIIIJ modulates the ACh-binding sites of the receptor by binding at an allosteric site. The rationale
for entertaining the latter possibility is to understand why C. magus venom has two structurally divergent
peptides (αMI and αM-MIIIJ) to accomplish the same physiological endpoint—incapacitation of the
nAChR. That is, perhaps α-MI acts orthosterically while αM-MIIIJ acts allosterically. This issue may
be resolved by experiments involving mutagenesis of specific residues in the nAChR subunits or by
examining whether αMI and αM-MIIIJ can act synergistically.
A species of fish-hunting Conus with three subfamilies of peptides that target muscle nAChRs is
C. ermineus, whose venom contains α-EI (an α-4/7 subfamily member), αA-EIVA/B (two closely-related
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αA-subfamily peptides that differ in only two residues), and the more recently-discovered α-EIIA
(Table 3). α-EI binds preferentially to the αδ interface of mouse nAChRs whereas αA-EIVA binds
equally well to both the αδ and αγ interfaces [33]. Our tests with α-EI on zebrafish muscle nAChRs
indicate that it blocks all three subunit combinations (αβδ, αβδε, and αβδγ) with similar potencies
(Figure 10). Furthermore, αM-MIIIJ completely protected against the block by α-EI of all three
subunit combinations (Figure 9A–C). It remains to be seen which sites αA-EIVA binds to on zebrafish
muscle nAChRs.
C. purpurascens is a fish-hunter with nAChR-targeting conotoxins belonging to three subfamilies:
α-PIB, αA-PIVA, and ψ-PIIIE/F (Table 3). ψ-PIIIE blocks IACh of X. laevis oocytes expressing Torpedo
nAChRs but does not compete with [125I]α-BgTX binding to Torpedo nAChRs [20]. Although the
binding site of ψ-PIIIE remains to be identified, it is clear that C. purpurascens venom has subfamilies
of conotoxins that block nAChRs via different modes or mechanisms. In this vein, it might be noted
that C. imperialis, a worm-hunting species of Conus, has two closely related α-conotoxins that block
α7 nAChRs, α-ImI and α-ImII [58,59]. While α-ImI competes with α-BgTX, α-ImII does not [58].
The binding of α-ImII to α7 nAChRs has been investigated [60], and its binding site and mechanism of
action were given the moniker “monkey wrench” [61].
It might be noted that there is the possibility thatαM-MIIIJ may act promiscuously, and its more (or
equally) important target in the wild is an ion channel other than muscle nAChRs; only further testing
will resolve this issue. There is precedent for a conotoxin affecting the function of more than a single
ion-channel target, for examples: µO-conotoxin MrVIA/B can block both V-gated Na and V-gated Ca
channels of snail neurons [62,63] (in addition to blocking vertebrate V-gated Na channels [64–66]);
µ-conotoxin CnIIIA, originally shown to block V-gated Na channels [12] can also block neuronal
nAChRs [67]; µ-conotoxins PIIIA and SIIIA, originally shown to block Na channels [15,23] can also
block K channels in the KV1 family [68]. Recently, an α-conotoxin from C. eburneus, Eu1.6, was
characterized that blocked (when tested at 1 µM) N-type voltage-gated Ca channels in dissociated
mouse dorsal root ganglion neurons. Among various rat nAChRs exogenously expressed in X. laevis
oocytes, 10 µM Eu1.6 blocked α7 nAChRs best (where IACh was attenuated by about a half) but had no
effect on skeletal muscle nAChRs with a subunit composition of αβδε [69].
4. Conclusions
αM-MIIIJ blocks the function of nAChRs in the postsynaptic membrane of skeletal muscles of fish
and frogs. The peptide also interferes with α-BgTX binding to these receptors. It is well established that
α-BgTX blocks nAChR function by occluding the ACh-binding sites on the receptor; by extension, we
conclude that αM-MIIIJ blocks nAChR function by interfering with ACh binding to nAChRs, although
it remains to be seen by how similar a mechanism as that of α-BgTX.
We reveal that αM-MIIIJ belongs to a new class of toxins from the M-superfamily and identify
several toxin sequences with significant sequence homology to αM-MIIIJ. We hypothesize that these
and additional homologs likely to be identified in the future will also function as muscle nAChR
antagonists. These studies will expand our understanding of the biology of fish hunting and the
versatility of toxins belonging to the M-superfamily, and further highlight the remarkable adaptability
of toxin genes in these marine predators.
5. Materials and Methods
5.1. αM-MIIIJ Purification and Sequencing
Crude venom was extracted from C. magus (~200 specimens) collected in waters surrounding
the island of Marinduque in the Philippines. Lyophilized venom was extracted with 1.1% v/v acetic
acid and chromatographed on a column of Sephadex G25 (2.5 × 92 cm) as previously described
(McIntosh et al., 1982 [8], method 3). Low molecular mass fractions were subsequently separated by
reversed-phased liquid chromatography (HPLC) on a Supelco LC18 semi-prep column (10 mm id ×
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25 cm; 5 µm particle size) at a flow rate of 3.0 mL/min. A 0.1% TFA–0.01% TFA, 60% acetonitrile buffer
system was used for elution. The gradient was 15% B × 5 min, increasing to 25% B at 25 min and
increasing to 60% B at 35 min. Absorbance was monitored at 210 nm.
Peptide from the final purification was stored in the HPLC buffer in which it eluted. A 287-µL
solution of this purified peptide (~250 pmol) was combined with 14.4 µL (20:1 v/v) of 0.5 M Tris base
which raised the pH to a value between 7 and 8 as measured with pH paper. Seventy-five µL of 50 mM
dithiothreitol was added (final concentration 10 mM); the reaction vessel was flushed with argon,
and the reaction incubated at 65 ◦C for 15 min. The solution was allowed to cool; 15 µL of 20% 4-vinyl
pyridine in ethanol was added, and the solution was reacted for a further 25 min at room temperature
in the dark. The solution was diluted 3-fold with 0.1% trifluoroacetic acid, and the alkylated peptide
was purified on the Brownlee column.
Sequencing was performed with Edman chemistry on an Applied Biosystems 477A (Applied
Biosystems, Foster City, CA, USA) Protein Sequencer at the Protein/DNA Core Facility at the University
of Utah Cancer Center (Salt Lake City, UT, USA). Mass spectrometry was performed as described
previously [9].
Initial attempts at sequencing yielded no sequence suggesting that the N-terminal residue might
be pyroglutamate as found in previously characterized conotoxins. We therefore subjected the peptide
to digestion with pyroglutamyl aminopepdtidease in an attempt to remove the potential pyroglutamate
and allow sequencing.
An amount of 400 µg of calf liver pyroglutamyl aminopepdtidease (Boehringer) enzyme powder
(~16 µg protein) and ~1 nmol of αM-MIIIJ was dissolved in 100 µL of incubation buffer consisting
of 50 mM Na2HPO4, pH 7.3, 10 mMβ-mercaptoethanol, 1 mM EDTA and incubated at 37 ◦C for
30 min. The reaction products were then purified by HPLC using a Vydac C18 4.6 mm ID column
using buffer A = 0.1% TFA and buffer B = 0.1% TFA, 60% acetonitrile buffer. The gradient was 20%
buffer B increasing to 50% buffer B over 30 min The resulting product was successfully sequenced.
5.2. Identification of Homologous Sequences
Using the mature toxin sequence of αM-MIIIJ we searched for homologous sequences in C. magus
and additional taser-and-tether hunting species from the Pionoconus clade (Conus consors and Conus
striatus) in published venom gland transcriptomes [14,17,70] using the Basic Local Alignment Search
Tool (BLAST) [71] with an e-value of <1 × 10−1.
5.3. αM-MIIIJ Synthesis
The peptide was manually assembled by solid-phase approach [72]. The starting Boc-Cys(Mob)-
CM resin with a capacity of 0.3 mmol/g was obtained according to published procedures [73]. All
Nα-tert-butyloxycarbonyl (BOC) protected amino acids with side chain protection were purchased
from Bachem Inc. (Torrance, CA, USA). The side chain protecting groups were as follows: Arg(Tos),
Asp(OChx), Cys(Mob), Lys(e-2ClZ), Ser(Bzl), Tyr(2BrZ). Z in the sequence represents pyroglutamic acid.
Three equivalents of Boc-amino acids based on the original substitution of the resin were used for
each coupling. The couplings of the protected amino acids were achieved by adding three equivalents
coupling reagents BOP (Benzotriazole-1-yl-oxy-tris(dimethylamino)-phosphoniumhexafluoro-
phosphate) or HBTU (O-(benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate)
in dichloromethane and dimethylformamide, respectively to the resin and adjusting the pH to 9
with diisopropylethylamine (DIPEA) then shaking it for 20 min. Completions of the couplings were
monitored by the qualitative ninhydrin test [74]. Boc removal was achieved by treatment with 60%
trifluoroacetic acid and 3% ethanedithiol in CH2Cl2 for 30 min. An isopropyl alcohol (containing
1% ethanedithiol) wash followed the TFA treatment and then successive washes with triethylamine
solution (10% in CH2Cl2), methanol, triethylamine solution, methanol and CH2Cl2 completed the
neutralization. The completed peptide was cleaved from the resin support with simultaneous side
chain deprotection by using anhydrous hydrogen fluoride containing the scavengers anisole (10% v/v)
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and methyl sulfide (1% v/v) at 0 ◦C for 75 min. The diethyl ether-precipitated crude peptide was
extracted from the resin with 50% isopropanol/ 50% water solution, the pH was adjusted to 8–8.5
with DIPEA and the mixture was slowly stirred for several days to complete the cyclization that was
monitored by the Ellman test [75]. The peptide was purified by preparative HPLC. The cartridge
used was hand packed, in house, with Waters polyethylene sleeve and frits and reversed-phase
300 Å Vydac C18 silica (15–20 µm particle size). The peptide was eluted with the solvent system 0.1%
TFA/H2O/CH3CN at a flow rate of 100 mL/min. A linear gradient 1.5% B per 1 min increases from the
baseline %B (Eluent A = 0.1% TFA/H2O, eluent B = 60% CH3CN, 40% A) was applied. Capillary zone
electrophoresis (CZE) was carried out on a Beckman P/ACE System 2050 controlled by an IBM Personal
System/2 Model 50Z connected to a ChromJet integrator. CZE analysis employed a field strength of
10–20 kV at 30 ◦C with a buffer of 15% CH3CN /85% 100 mM sodium phosphate pH 2.5 on a Beckman
eCAP capillary (363 mm o.d. 75 mm i.d. 50 cm length), LSIMS mass spectra were obtained with a JEOL
JMS-HX110 double-focusing mass spectrometer (JEOL, Tokyo, Japan) fitted with a Cs+ gun.
The experiments described in this report employed synthetic αM-MIIIJ.
5.4. Animal Use
Use of all animals in this study followed protocols approved by the University of Utah Institutional
Animal Care and Use Committee (IACUC) that conform to the National Institutes of Health Guide for
the Care and Use of Laboratory Animals. IACUC protocols were as follows: #14-08018 (approved
period, 20 August 2014–19 August 2017) and #17-07020 (approved period, 01 August 2017–31 July
2020). Mice were euthanized with CO2. X. leavis and fish were anesthetized with Tricaine (0.4% for
X. laevis and goldfish, 0.02% for zebrafish) and decapitated. R. pipiens were sacrificed by double pithing.
5.5. In Vivo Bioassays of αM-MIIIJ on Goldfish and Mice
Carassius auratus (goldfish). Toxin was dissolved in 0.9% w/v NaCl (NSS), and 10 µL were injected
into the dorsal epaxial muscle of a given fish. The fish was then placed in a beaker (14.5 cm dia. ×
7.5 cm height) containing ~700 mL of water with a 35-mm long, 10-mm diameter magnetic stir bar
rotating at ~200 RPM creating a vortex, such that the fish must actively swim to avoid being trapped in
the center. Each of three control fish injected with NSS alone were able to swim with no sign of being
overpowered by the vortex for >35 min. Fish injected with αM-MIIIJ gradually became paralyzed
within several minutes and were unable to escape the vortex. After paralysis, fish were moved to
250 mL beakers to be observed. Motion of the mouth and gills was observed, but fish were unable to
swim and did not respond to prodding of fins, dorsal and ventral sides, and eyes.
Mice. Swiss Webster mice (~13 g avg. weight) were injected intraperitoneally (i.p.) with ~2.3 nmol
αM-MIIIJ/gram mouse dissolved in 30 µL NSS. Control mice were injected with 30 µL NSS only. After
injection, mice were observed for >1.5 h for signs of paralysis.
5.6. Isolated Muscle Preparations
Rana pipiens (grass frog). The cutaneous pectoralis (aka cutaneus pectoris, CP) muscle of Rana
pipiens (~65 mm) long adults of both sexes) was used. This flat, thin muscle has long served as a go-to
preparation for studies of the structure and function of frog neuromuscular synapses (see e.g., [34,76,77]).
For extracellular recording, the muscle was prepared and used as previously described [78]. For
fluorescence microscopy, the preparation was pinned with 0.1 or 0.2 mm dia. stainless steel Minutien
pins to coverslips (22 mm dia.) coated with Sylgard (Dow Corning, Midland, MI, USA), a transparent
silicone elastomer.
Xenopus laevis (African clawed frog). These frogs do not have CP muscles, therefore we used
their longitudinal pectoralis (LP) muscles, which are flat muscles that lie laterally on either side of
the rectus abdominus muscle of the animal [79]. The motor nerve contacts the muscle near the rostral
end and sends branches that run parallel with the muscle fibers. For extracellular recording, strips of
LP muscles of adult animals were used. A given strip was placed in a multi-well chamber fabricated
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from Sylgard where the wells, each 4-mm diameter and 4-mm deep, were in a linear array with
a 1 mm-partition separating one well from the next. The rostral end of the strip was placed in well 1
and the caudal end in well 5 to 8, depending on the strip’s length. The portion of the muscle strip
overlying a partition was covered with Vaseline. A pair of stimulating electrodes were located in wells
1 and 2 or wells 2 and 3; with a ground electrode located in well 3 in the former case, and in well 4 in
the latter. A pair of recording electrodes were located in adjacent wells 4 and 5, 5 and 6, 6 and 7, or 7
and 8 (depending on muscle length). To obtain indirectly-evoked muscle action potentials without
confounding, directly-evoked muscle action potentials, 10 µM µ-conotoxin PIIIA, which specifically
blocks the muscle subtype of V-gated Na channels [23], was present in the two wells in which the
stimulating electrodes were located; thus, only the motor nerve was directly activated by the electrical
stimulus. In a separate set of experiments, muscle action potentials in response to direct stimulation
were recorded by having 10 µM d-tubocurare in all wells to block synaptically-mediated responses.
Excitatory postsynaptic responses evoked by indirect stimulation were recorded by placing 10 µM
µ-conotoxin PIIIA in all wells.
For intracellular recording and fluorescence microscopy, we used LP muscles from ~5-cm juveniles
of either sex. Cutting the muscle longitudinally approximately in half, a procedure that did not
denervate the majority of the fibers in the medial half, allowed the remaining muscle to fit in a ~23-mm
diameter, ~2-mm deep recording chamber or be pinned onto a Sylgard-coated coverslip (22 mm dia.).
Carassius auratus (goldfish). We discovered that the intercostal (IC) muscles of adult goldfish
can be easily prepared for electrophysiology and are readily amenable for fluorescence microscopy
following vital staining. Briefly, goldfish (~4-cm long) of undetermined sex were anesthetized with 0.4%
Tricaine, decapitated, and its skin descaled by plucking with serrated forceps. A pair of sharp-tipped
scissors was used to make a longitudinal incision in the body wall along the ventral midline from
anal fin to pelvic fin, with care taken to avoid cutting any entrails. This was followed, on each side of
the animal, by two vertical incisions in the body wall from the ventral midline, dorsally to the spine:
one from the anal fin and the other from the pelvic fin. Finally, each half of a rib cage, with its skin
intact, was cut along the spine to free each hemi-rib cage from the rest of the animal. Each hemi-rib
cage was pinned, skin-side down, in a Sylgard-coated plastic culture dish containing NFR, and the
iridophore-laden parietal peritoneal integument overlying the inner surface of the ribs was carefully
stripped away manually with tweezers to expose the two diagonally-overlapping layers of intercostal
muscles. The intercostal muscle preparation, consisting of at least four ribs, was then pinned skin-side
down to a Sylgard-coated coverslip (22-mm diameter). Two such preparations can be readily obtained
from each side of a given goldfish.
Danio rerio (zebrafish). Briefly, larval zebrafish (4- to 6-day old), anesthetized with 0.02%
Tricaine and decapitated, were pinned on their sides to a Sylgard-coated coverslip (15-mm dia.)
with electrolytically-sharpened tungsten pins [80] essentially as described by Brehm’s laboratory [81].
The skin on the uppermost side of each fish was then peeled away so toxins could readily access the
underlying body musculature [81,82]. The transparency of the skin in these larval fish allowed the
muscle fibers closest to the coverslip to be readily imaged with an inverted microscope. Slow fibers are
distinguished by nAChRs localized largely to the myoseptal regions (at the ends of the muscle fibers),
while fast muscles are invested with nAChRs distributed in clusters or puncta dispersed throughout
a given muscle fiber (for review see [30]).
Mice. The levator auris longus (LAL) muscle initially described for electrophysiology by Faille
and coworkers was used [83]. This thin, flat muscle preparation, which allowed ready access and
egress of drugs, was pinned in a rectangular trough (~5 × 15 × 4 mm deep) and the motor nerve was
draped across two adjacent wells (~4 mm dia. × 4 mm deep) and into the muscle-containing trough
(all partitions were 1 mm wide and they, along with the overlying nerve, were covered with Vaseline).
The chamber was fabricated from Sylgard.
Solutions. Both frog and fish muscle preparations were bathed in normal frog Ringer’s (NFR),
which consisted of (in mM): NaCl (111); KCl (2); CaCl2 (1.8); and half-Na HEPES (10 mM), pH 7.2.
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Mouse muscle preparations were bathed in normal mammalian Ringer’s (NMR) composed of (in mM):
NaCl (145); KCl (5); CaCl2 (2); sodium citrate (1); glucose (10); and half-Na HEPES (10 mM), pH 7.4.
5.7. Muscle Electrophysiology
Extracellular recordings were acquired with a pair of wire electrodes connected to a Grass P55 A.C.
preamplifier at an amplification of 100 or 1000 and bandpass filtered with −6 dB cut-off frequencies of
1 Hz (unless otherwise indicated) and 1 kHz. The output of the preamp was digitized at a sampling
rate of 10 kHz with an NI PCI-6221 data acquisition board (National Instruments, Austin, TX, USA).
Motor-nerve stimulation was accomplished with either a pair of wire electrodes, one each in the
nerve-containing wells (R. pipiens CP, adult X. laevis LP, mouse LAL preparations) or a suction electrode
(juvenile X. laevis LP preparation). The stimulating electrodes were connected to a Grass Stimulus
Isolation Unit (“SIU5A”) driven by a Grass S88 stimulator (Grass Instruments, Quincy, MA, USA) that
was set to deliver a supermaximal stimulus (~10 V, 0.1-ms rectangular pulse) at a frequency of 1/20 sec.
Responses were recorded with a pair of extracellular recording electrodes in the trough: one electrode
located near the middle of the muscle, and the other near the caudal end of the muscle. A ground
electrode was located in the trough between the stimulating and recording electrodes. All extracellular
electrodes were stainless steel. For all electrophysiological recordings, timing of stimuli, and data
acquisition, storage and retrieval were performed with home-made software written with LabVIEW
(National Instruments, Austin, TX, USA).
Intracellular recordings were acquired with glass microelectrodes filled with 3 M KCl (X. laevis LP
muscle) or 4M K-acetate (goldfish IC muscle) (~5 MΩ resistance) and a MultiClamp 700B amplifier
(Molecular Devices, Sunnyvale, CA, USA) in current-clamp mode with current clamped at zero pA,
where membrane potentials were amplified 10-fold, high-frequency filtered at 1 kHz. (Note, KCl is the
conventional electrolyte used to fill intracellular microelectrodes for recording from frog skeletal muscle
(e.g., ref. [84]). Although K-acetate-filled microlectrodes are less popular, they have been used to record
from goldfish skeletal muscle (see e.g., [85] We used 3 M KCl and 4M K-acetate solutions because we
happened to have these on hand.) The output of the amplifier was digitized and synchronized with
the stimulator using the hardware and software described above for extracellular recording. Insertion
of the intracellular electrode at a location near an NMJ of an X. laevis LP fiber was assisted by use of
fluorescein peanut agglutinin (f-PNA, see Section 5.9 below). NMJs of goldfish IC fibers are distributed
all along a given fiber, so spontaneous miniature excitatory potentials (MEPSPs) were readily recorded
regardless of electrode placement. Amplitudes of MEPSPs were measured manually.
Acetylcholine (ACh) iontophoresis was performed in a manner similar to that previously
described [84]. In essence, a Grass Instruments S-44 stimulator in conjunction with a home-made
stimulus isolation unit (SIU) was used. One output of the SIU led to one terminal of “brake box”
consisting of a 9-V battery whose output was regulated by a potentiometer. The other terminal of the
brake box was connected to a 100 MΩ current-limiting resistor located close to, and in series with,
a chlorided silver wire that was inserted into a glass micropipette filled with 1 M ACh•Cl and whose
resistance was about 10 MΩ. The other output of the SIU let to a chlorided silver wire bath electrode
that provided the return path for ACh current. A (negative) braking current of ~15 nA was used to
prevent desensitization-inducing ACh from leaking out of the pipette, while ACh was ejected from the
micropipette with a 10-ms (positive) current pulse whose amplitude was adjusted to obtain ACh-gated
depolarizations in the ~10 mV range. The ACh-filled micropipette was placed near an NMJ under
visual control assisted by the use of f-PNA (see Section 5.9 below).
5.8. Voltage-Clamp of X. laevis Oocytes Exogenously Expressing Muscle nAChRs from Zebrafish, Mouse,
and Human
cDNA clones of α-, β- (β1b isoform), γ-, ε-, and δ-subunits of the muscle subtypes of nAChR from
zebrafish [25] were generously provided by Paul Brehm. cRNA were produced from these clones by
linearizing with BamHI and transcription with T7 (mMessage mMachine T7 kit, Invitrogen, Carlsberg,
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CA, USA). cRNA injections and voltage-clamping of ACh-gated currents were done essentially as
previously described [9]. Briefly, a given oocyte was injected with ~1 ng of cRNA for each nAChR
subunit in the following combinations: αβδγ (fast embryonic muscle) or αβδε (fast larvae and adult
muscle) or αβδ (slow muscle) and incubated at 16 ◦C for at least one day. The same was done for the
αβε subunit combination except ~10 ng of cRNA were injected for each subunit. Preparation and
injection into oocytes of the following materials were as previously described: cDNA for mouse and
human muscle nAChR [55]; cRNA for rat α3β4 and α4β2 and human α9α10 nAChRs [9,86].
To record ACh-gated currents (IACh), an oocyte was placed in a 30 µL chamber, perfused with
ND96 (96.0 mM NaCl, 2.0 mM KCl, 1.8 mM CaCl2, 1.0 mM MgCl2, 5 mM Hepes, pH 7.1–7.5) containing
0.1 mg/mL bovine serum albumin, two-electrode voltage clamped at a holding potential of −70 mV
with an OC725C Oocyte Clamp amplifier (Warner Instruments, Hamden, CT, USA), and exposed to
a 1-s pulse of ACh (10 µM for all nAChRs except zebrafish αβε-subunit combination where [ACh] was
100 µM) delivered at a frequency of 1/min. Oocytes were exposed to toxin in a static bath for 5-min. by
halting the perfusion (and ACh pulses) and applying 3 µL of toxin to the chamber at 10-times the final
concentration and stirring the bath by aspirating and expelling the mixture with a pippetor. The same
was done for control responses except 3 µL ND96 was introduced into the static bath instead of peptide.
After the five minutes had expired, the ACh pulses (and perfusion) were resumed. The peak amplitude
of the first IACh response after the 5-min ND96 control exposure served as the control response, and the
peak amplitude of the first IACh response after the 5-min toxin exposure served as the test response.
The ratio of the test/control response was multiplied by 100 to obtain the percentage response. Each
data point of a concentration–response curve represents the average ± S.E. of at least three oocytes.
Concentration–response curves were fit, with Prism software (GraphPad Software Inc., San Diego,
CA), to the Langmuir adsorption isotherm: % Block = 100%/{1 + (IC50/[toxin])}.
5.9. Fluorescence Imaging
5.9.1. Imaging of Fluorescently-Tagged α-bungarotoxin (α-BgTX) and Fluorescein Peanut Agglutinin
(f-PNA) Bound at NMJs
Tetramethylrhodamine (TMR)α-BgTX and fluorescein PNA were used essentially as first described
by the laboratories of Cohen and Ko, respectively [34,87]. TMR α-BgTX and Alexa-488 α-BgTX were
purchased from Molecular Probes (Eugene, OR, USA) and used at concentrations and exposure times
detailed in Results. Fluorescein-PNA was purchased from Vector Laboratories (Burlingame, CA, USA),
and muscles were exposed to it at a concentration of 50 µg/mL for 20–30 min. f-PNA was originally
used with R. pipiens NMJs, where it was shown not to adversely affect synaptic transmission [87].
We found that f-PNA also could serve in that capacity with X. laevis LP muscles (see Figure 13B); in
contrast, we found that f-PNA was not useful as a marker for NMJs in fish.
Frog and goldfish muscle preparations were imaged with a Nikon FN-1 (upright) microscope
fitted with a Nikon Apo 40X/0.8 water-immersion objective and a Nikon Digital Sight DS-Qi1Mc
camera using a 2-s exposure at a gain of 8. Zebrafish muscle preparations were imaged with a Nikon
Ti (inverted) microscope fitted with Nikon Plan Fluor 40X/0.75 objective and a Retiga SRV-1394 camera
(QImaging, Surrey, BC, Canada) with a 1-s exposure at a gain of 10. All images were acquired and
processed with Nikon NIS-Elements software.
5.9.2. Fluorescence Intensity Measurements
The level of fluorescently tagged α-BgTX bound at NMJs was quantified as follows. For frog
muscles, a rectangular region of interest (ROI) with a width of 16 pixels (2.56 µm) was placed over the
NMJ with the ROI’s long axis perpendicular to the long axis of the NMJ. A profile plot was obtained
from the ROI where the plot’s Y-axis represented fluorescence intensity averaged over the pixels in
the short dimension of the ROI, and the plot’s X-axis represented distance (in µm) along the long
dimension of the ROI (for an example, see Panels C and H in Figure 13). The value of the profile’s peak
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minus that of the flanking baseline was taken as the fluorescence-intensity level. The same was done
for fish muscles except the width of the rectangular ROI was narrower (6 pixels), and only NMJs were
measured whose larger dimension exceeded the width of the ROI (see Figure S2B).
5.10. Toxins and Their Application
αM-MIIIJ was synthesized as described in Results. α-conotoxin EI (α-EI), from C. ermineus, was
synthesized as previously reported [22]. Toxins were dissolved in distilled water, NFR, NMR, or ND96,
and stock solutions were kept frozen until use. Unless indicated otherwise, the solution bathing the
preparation was manually removed and replaced by a toxin solution; static baths were used throughout
to conserve toxin. Toxins were washed out by manually replacing the bath solution with NFR or NMR;
in the case of oocytes, the bath was gravity perfused with ND96.
All experiments were performed at room temperature.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6651/12/3/197/s1,
Figure S1: HPLC elution profile of C. magus venom. Figure S2: αM-MIIIJ (10 µM) inhibits fluorescently-tagged
α-BgTX binding at neuromuscular junctions of goldfish intercostal muscles, Figure S3: αM-MIIIJ (10 µM) inhibits
binding of fluorescently-tagged α-BgTX at both septal and distributed neuromuscular junctions in zebrafish,
Table S1: Paralysis of goldfish induced by intramuscular injection of αM-MIIIJ.
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